EnsoData, a leading provider of artificial intelligence (AI) solutions to assist with sleep testing, diagnosis, and treatment, and React Health, a sleep and respiratory device manufacturer based in Sarasota, FL, have announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea.
EnsoData’s revolutionary adherence prediction AI will be integrated into React Health’s recently launched React Health Connect platform. This collaboration will empower referring physicians and DME suppliers with actionable data to provide timely, personalized support to patients who are struggling with therapy adherence.
“By partnering with EnsoData, we are making another significant investment in our sleep therapy product portfolio”, says Tom Pontzius, President at React Health. “EnsoData’s predictive analytics will allow our customers to prioritize and focus on the patients that need intervention the most, and will ultimately provide a more personalized and positive patient experience.”
“Our PAP compliance AI model has an incredible ability to predict compliance within days of starting treatment,” states Chris Fernandez, Chief Research Officer. “We are excited about the transformative impact our technology can have on the multitude of patients who face challenges in treating their sleep apnea. Our goal is to strengthen the bond between healthcare providers and patients, resulting in improved patient outcomes.”
This partnership signifies a new era in personalized sleep apnea care where predictive clinical AI tools enable timely patient care, increased patient support, and stronger provider-patient connection.
Source: EnsoData
Pingback: Colleen Lance, MD Joins React Health as CMO - RTSleepWorld